Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
ASAsensus Surgical, Inc. logo

Asensus Surgical, Inc. (ASXC)

New York Stock Exchange Arca · Currency in USD
$0.35 ▲ +0.00 (+0.64%)
At close: Aug 21, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.35
Open
$0.35
Day's Range
$0.35 – $0.35
52 Week Range
$0.17 – $0.40
Volume
3,942,270
Avg. Volume
3,060,335
Market Cap
$94.92M
Beta (5Y Monthly)
1.38
PE Ratio (TTM)
--
EPS (TTM)
-$0.31
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$1.50

Profile: Asensus Surgical, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
207
CEO
Anthony Fernando

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards.

Earnings

DateEst.Actual
Aug 13, 2024-$0.05-$0.07Miss
May 14, 2024-$0.05-$0.07Miss
Mar 21, 2024-$0.05-$0.07Miss
Nov 14, 2023-$0.07-$0.06Beat
Aug 10, 2023-$0.08-$0.09Miss
May 11, 2023-$0.07-$0.09Miss

Analyst view

Consensus price target
$1.50 ▲ +331.2%
Range $1.50 – $1.50
Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on ASXC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.